Fukushima T, Sumazaki R, Koike K, Tsuchida M, Matsui A, Nakauchi H
Department of Pediatrics, Ibaraki Children's Hospital, Mito, Japan.
J Pediatr Hematol Oncol. 1998 May-Jun;20(3):222-8. doi: 10.1097/00043426-199805000-00007.
To characterize nonleukemic CD10-positive cells in the marrows of children with leukemia in remission or benign conditions.
Seventeen children with acute leukemia in complete remission, 12 with solid tumors, and 17 with benign blood diseases were included in this study. Bone marrow cells were analyzed by multicolor flow-cytometry and polymerase chain reaction (PCR) to detect immunoglobulin gene rearrangement. The CD10-positive cells were purely sorted and examined by light microscopy and single cell hemopoietic progenitor assay.
In patients with acute leukemia, CD10-positive cells were present in higher proportion after completion of therapy than during chemotherapy. They were also higher in the patients of preschool age than in the older age group with benign blood diseases and solid tumors. These CD10-positive cells were morphologically compatible with immature lymphocytes but some blast-like cells also occurred in this population. Most CD10-positive cells coexpressed CD19 and HLA-DR, although only 10 to 30% coexpressed CD20 and CD34. Although some CD10-positive cells expressed CD34, they did not make any colonies. PCR analysis did not show monoclonal bands in CD10-positive bone marrow cells in any patients in remission.
Marrow CD10-positive cells possess immature B-lymphocyte phenotype and are present in higher proportion in the marrows of children with acute leukemia in continuous complete remission after completion of therapy and children of preschool age than school-age children with benign diseases or solid tumors without marrow involvement. The clonality of these cells was excluded by PCR, which is a distinct point from CD10-positive ALL blasts.
对处于缓解期的白血病患儿或患有良性疾病患儿骨髓中的非白血病性CD10阳性细胞进行特征描述。
本研究纳入了17例急性白血病完全缓解患儿、12例实体瘤患儿和17例良性血液病患儿。采用多色流式细胞术和聚合酶链反应(PCR)分析骨髓细胞,以检测免疫球蛋白基因重排。对CD10阳性细胞进行纯分选,并通过光学显微镜和单细胞造血祖细胞分析进行检查。
在急性白血病患者中,治疗完成后CD10阳性细胞的比例高于化疗期间。学龄前患者中的CD10阳性细胞比例也高于患有良性血液病和实体瘤的大龄组患者。这些CD10阳性细胞在形态上与未成熟淋巴细胞相符,但该群体中也出现了一些原始样细胞。大多数CD10阳性细胞共表达CD19和HLA-DR,尽管只有10%至30%共表达CD20和CD34。虽然一些CD10阳性细胞表达CD34,但它们未形成任何集落。PCR分析未显示任何缓解期患者的CD10阳性骨髓细胞中有单克隆条带。
骨髓CD10阳性细胞具有未成熟B淋巴细胞表型,在治疗完成后持续完全缓解的急性白血病患儿以及学龄前患儿的骨髓中所占比例高于无骨髓受累的良性疾病或实体瘤学龄儿童。PCR排除了这些细胞的克隆性,这是与CD10阳性急性淋巴细胞白血病原始细胞的一个明显区别点。